Multi-centred mixed-methods PEPFAR HIV care & support public health evaluation: Study protocol

BMC Public Health

Volumn 10, Issue , 2010, Pages

  Harding, Richard ^a   Simms, Victoria ^a   Penfold, Suzanne ^a   McCrone, Paul ^b   Moreland, Scott ^c   Downing, Julia ^d   Powell, Richard A ^d   Mwangi Powell, Faith ^d   Namisango, Eve ^d   Fayers, Peter ^e   Curtis, Siân ^f   Higginson, Irene J ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c African Palliative Care Association ^*  (United States)

^d AFRICAN PALLIATIVE CARE ASSOCIATION   (Uganda)

^e UNIVERSITY OF ABERDEEN   (United Kingdom)

^f UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL TRIAL; COST; CROSS-SECTIONAL STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFORMATION PROCESSING; INTERVIEW; KENYA; METHODOLOGY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PUBLIC HEALTH; SOCIAL SUPPORT; UGANDA;

COSTS AND COST ANALYSIS; CROSS-SECTIONAL STUDIES; FOCUS GROUPS; HIV INFECTIONS; HUMANS; INTERVIEWS AS TOPIC; KENYA; OUTCOME ASSESSMENT (HEALTH CARE); PUBLIC HEALTH; RESEARCH DESIGN; SOCIAL SUPPORT; UGANDA;

EID: 77957164487     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-10-584     Document Type: Article

References (45)

1. HIV and AIDS estimates and data, 2007 and 2001 from the 2008 report on the global AIDS epidemic. UNAIDS, 2008
2. The President's Emergency Plan for AIDS Relief in Africa: an evaluation of outcomes. E Bendavid J Bhattacharya, Ann Intern Med 2009 150 688 695 19349625
3. Contraception to prevent HIV-positive births: current contribution and potential cost savings in PEPFAR countries. HW Reynolds B Janowitz R Wilcher W Cates, Sex Transm Infect 2008 84 Suppl 2 i49 ii53 10.1136/sti.2008.030049 18799493
4. Improving HIV management in sub-Saharan Africa: How much palliative care is needed? K Collins R Harding, AIDS Care 2007 19 1304 1306 10.1080/ 09540120701402863 18071975
5. Suicidal ideation in UK HIV clinic attenders. L Sherr F Lampe M Fisher G Arthur J Anderson S Zetler,, et al. AIDS 2008 22 1651 1658 10.1097/QAD. 0b013e32830c4804 18670226
6. Depressive symptoms increase risk of HIV disease progression and mortality among women in Tanzania. G Antelman S Kaaya R Wei J Mbwambo GI Msamanga WW Fawzi,, et al. J Acquir Immune Defic Syndr 2007 44 470 477 10.1097/QAI.0b013e31802f1318 17179766
7. Mental distress in the general population in Zambia: impact of HIV and social factors. PJ Chipimo K Fylkesnes, BMC Public Health 2009 9 298 10.1186/1471-2458-9-298 19689799
8. Differences in normal activities, job performance and symptom prevalence between patients not yet on antiretroviral therapy and patients initiating therapy in South Africa. S Rosen M Ketlhapile I Sanne MB Desilva, AIDS 2008 22 Suppl 1 131 S139 10.1097/01.aids.0000327634.92844.91 18664945
9. Macronutrient supplementation for malnourished HIV-infected adults: a review of the evidence in resource-adequate and resource-constrained settings. JR Koethe BH Chi KM Megazzini DC Heimburger JS Stringer, Clin Infect Dis 2009 49 787 798 10.1086/605285 19624276
10. Peripheral neuropathy in HIV-positive patients at an antiretroviral clinic in Lilongwe, Malawi. WI Beadles A Jahn R Weigel D Clutterbuck, Trop Doct 2009 39 78 80 10.1258/td.2008.080213 19299286
11. Symptom burden in HIV infected adults at time of HIV diagnosis in rural Uganda. K Wakeham R Harding D Bamukama J Levin J Kissa R Parkes,, et al. Journal of Palliative Medicine 2010 13 375 380 10.1089/jpm.2009.0259 20384499
12. Provision of pain and symptom-relieving drugs for HIV/AIDS in Sub-Saharan Africa. R Harding RA Powell F Kiyange J Downing F Mwangi-Powell, Journal of Pain & Symptom Management 2010 40 405 415
13. Experiences and support needs of poverty-stricken people living with HIV in the Potchefstroom district in South Africa. AT Feitsma MP Koen AJ Pienaar CS Minnie, J Assoc Nurses AIDS Care 2007 18 55 64 10.1016/j.jana.2007.03.006 17570300
14. Meeting information needs of patients with incurable progressive disease and their families in South Africa and Uganda: multicentre qualitative study. L Selman IJ Higginson G Agupio N Dinat J Downing L Gwyther,, et al. BMJ 2009 338 1326 10.1136/bmj.b1326 19386672
15. Publishing study protocols. F Godlee, BMC News and Views 2001 2
16. "Is there anything else you would like to tell us" - methodological issues in the use of free-text comments from postal surveys. J Garcia J Evans M Reshaw, Quality and Quantity 2004 38 113 125 10.1023/B:QUQU.0000019394.78970.df
17. Development and validation of a core outcome measure for palliative care: the palliative care outcome scale. Palliative Care Core Audit Project Advisory Group. J Hearn IJ Higginson, Qual Health Care 1999 8 219 227 10.1136/qshc.8.4.219 10847883
18. Relationship between three palliative care outcome scales. IJ Higginson N Donaldson, Health Qual Life Outcomes 2004 2 68 10.1186/1477-7525-2-68 15566627
19. Validation of a core outcome measure for palliative care in Africa: the APCA African Palliative Outcome Scale. R Harding L Selman G Agupio N Dinat J Downing L Gwyther,, et al. Health and Quality of Life Outcomes 2010 8 10 10.1186/1477-7525-8-10 20100332
20. Development of the APCA African Palliative Outcome Scale. RA Powell J Downing R Harding F Mwangi-Powell S Connor, J Pain Symp Manage 2007 33 229 232 10.1016/j.jpainsymman.2006.10.008
21. Toxicity and response criteria of the Eastern Cooperative Oncology Group. MM Oken RH Creech DC Tormey J Horton TE Davis ET McFadden,, et al. American Journal of Clinical Oncology 1982 5 649 655 10.1097/00000421-198212000-00014 7165009
22. A Bowling, Measuring Disease Buckingham: Open University Press 2 2001
23. Measuring quality of life among HIV-infected women using a culturally adapted questionnaire in Rakai district, Uganda. TC Mast G Kigozi F Wabwire-Mangen R Black N Sewankambo D Serwadda,, et al. AIDS Care 2004 16 81 94 10.1080/09540120310001633994 14660146
24. The MOS short-form general health survey: reliability and validity in a patient population. AL Stewart RD Hays JE Ware Jr, Med Care 1988 26 724 735 10.1097/00005650-198807000-00007 3393032
25. Costing psychiatric interventions. J Beecham M Knapp, Measuring Mental Health needs London: Gaskell, Thornicroft G, 2001
26. International Drug Price Indicator Guide 2010. http://erc.msh.org/ mainpage.cfm?file=1.0.htm&module=DMP&language=English Accessed July 2010.
27. Argo - Tech Materials Laboratory. ATC Labs, http://www.atclabs.com/ Accessed July 2010.
28. Socioeconomic differences in health nutrition and population in Ghana. DR Gwatkin S Rustein K Johnson RP Pande A Wagstaff, World Bank. HNP/Povery Thematic Group of the World Bank 2000
29. Use of traditional herbal medicine by AIDS patients in Kabarole District, western Uganda. D Langlois-Klassen W Kipp GS Jhangri T Rubaale, Am J Trop Med Hyg 2007 77 757 763 17978084
30. HIV/AIDS Palliative Care Guidance #1 for the United States Government In-Country Staff and Implementing Partners. Office of the Global AIDS Coordinator, U.S. Department of State 2006
31. Efficacy of voluntary HIV-1 counselling and testing in individuals and couples in Kenya, Tanzania, and Trinidad: a randomised trial. The Voluntary HIV-1 Counselling and Testing Efficacy Study Group, Lancet 2000 356 103 112 10.1016/S0140-6736(00)02446-6 10963246
32. The spectrum of symptoms among rural South Africans with HIV infection. ER Shawn L Campbell MB Mnguni KM Defilippi AB Williams, J Assoc Nurses AIDS Care 2005 16 12 23 10.1016/j.jana.2005.09.002 16536261
33. Palliative care: symptom management and end of life care. IMAI: interim guidelines for first-level facility health workers in low-resource settings. World Health Organisation, http://www.who.int/3by5/publications/documents/en/ genericpalliativecare082004.pdf Accessed 27/09/10
34. Efficacy of a vibratory stimulus for the relief of HIV-associated neuropathic pain. JA Paice S Shott FP Oldenburg J Zeller B Swanson, Pain 2000 84 296 10.1016/S0304-3959(99)00217-1
35. Symptoms of HIV disease. JP Welch D Barlow PH Richardson, Palliat Med 1991 5 46 51 10.1177/026921639100500109
36. The symptom experience of people living with HIV/AIDS in Southern Africa. LN Makoae NM Seboni K Molosiwa M Moleko S Human NA Sukati,, et al. J Assoc Nurses AIDS Care 2005 16 22 32 10.1016/j.jana.2005.03.005 16433114
37. Effect of co-trimoxazole prophylaxis, antiretroviral therapy, and insecticide-treated bednets on the frequency of malaria in HIV-1-infected adults in Uganda: a prospective cohort study. J Mermin JP Ekwaru CA Liechty W Were R Downing R Ransom,, et al. Lancet 2006 367 1256 1261 10.1016/S0140-6736(06)68541- 3 16631881
38. Cost-effectiveness of cotrimoxazole prophylaxis among persons with HIV in Uganda. C Pitter JG Kahn E Marseille JR Lule DA McFarland JP Ekwaru,, et al. J Acquir Immune Defic Syndr 2007 44 336 343 10.1097/QAI.0b013e31802f12b5 17327758
39. Cotrimoxazole prophylaxis for opportunistic infections in adults with HIV. K Grimwade G Swingler, Cochrane Database of Systematic Reviews 2003 D003108
40. Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural Uganda. D Moore C Liechty P Ekwaru W Were G Mwima P Solberg,, et al. AIDS 2007 21 713 719 10.1097/QAD.0b013e328013f632 17413692
41. JWR Twisk, Applied Longitudinal Analysis for Epidemiology: a practical guide Cambridge: Cambridge University Press 2003
42. Generating an African palliative care evidence base: the context, need, challenges, and strategies. R Harding RA Powell J Downing SR Connor F Mwangi-Powell K Defilippi,, et al. J Pain Symptom Manage 2008 36 304 309 10.1016/j.jpainsymman.2008.04.008 18722312
43. Adherence to HIV antiretroviral therapy in HIV+ Ugandan patients purchasing therapy. J Byakika-Tusiime JH Oyugi WA Tumwikirize ET Katabira PN Mugyenyi DR Bangsberg, Int J STD AIDS 2005 16 38 41 10.1258/0956462052932548 15705271
44. Determinants of adherence to highly active antiretroviral therapy among HIV-1-infected patients in Cote d'Ivoire. S Diabate M Alary CK Koffi, AIDS 2007 21 1799 1803 10.1097/QAD.0b013e3282a5667b 17690579
45. Patterns of individual and population-level adherence to antiretroviral therapy and risk factors for poor adherence in the first year of the DART trial in Uganda and Zimbabwe. SK Muyingo AS Walker A Reid P Munderi DM Gibb F Ssali,, et al. J Acquir Immune Defic Syndr 2008 48 468 475 10.1097/QAI.0b013e31817dc3fd 18614918